Samsung Biologics Inks Manufacturing Deal with Asian Pharmaceutical Company
With the latest agreement, the company's accumulated contract for 2024 surpasses USD 3.3 billion.
ADC Facility | 22/10/2024 | By Aishwarya | 106
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy